NCT01069575 2019-03-19
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer
Shiga University
Phase 1 Completed
Clinical Trials
5 trialsNCT01069640 2019-03-19
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer
Shiga University
Phase 1 Completed
NCT00753844 2012-04-06
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer
Kinki University
Phase 1 Completed
NCT00676949 2011-06-23
peptidevac
Kyushu University
Phase 1 Completed
NCT00561275 2008-07-15
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
Japanese Foundation for Cancer Research
Phase 1 Completed